AVaTAR MedTech Completes the IDEA² Program at MIT linQ

Seven months of innovation training, expert mentoring, and strategic development at MIT linQ.

Tomás Armendariz
Read de original post

AVaTAR MedTech is thrilled to announce the successful completion of the IDEA² program, conducted at MIT linQ in Boston.

Over the past seven months, this transformative biomedical accelerator provided us with world-class innovation training, specialized workshops, and tailored mentoring from international experts.

Through the program, we strengthened our storytelling for each stakeholder, refined our regulatory strategy, and advanced our go-to-market approach, product development plan, and commercialization roadmap. We also deepened our understanding of the healthcare economic buyer and sharpened our value proposition, clearly defining it across all stakeholders in the healthcare system, as we continue advancing our mission to bring life-changing pediatric heart valve solutions to patients worldwide.

We extend our heartfelt thanks to the IDEA² MIT linQ team, especially Mercedes Balcells-Camps, Martha Gray, Eric Norman, and our exceptional mentors: Nancy Levy, F. David Rothkopf, Michael Naimark, Arthur Hiller, Isaac Tourgeman, Michael Dempsey, Carlos Castro Gonzalez, and Paul Hartung, for their guidance, expertise, and commitment to elevating projects like ours.

To any innovators considering applying to IDEA²: we highly recommend it. It is an intense, invaluable journey that accelerates both vision and execution.

Related posts

Coming soon